2020 Will Be a Year to Remember for These 3 Healthcare Stocks
The global pandemic changed a lot of plans in 2020. Jobs were lost, vacations were canceled, and remote learning became the norm. But as disruptive as the coronavirus has been, for some companies it offered an opportunity to expedite research and apply existing therapies in a new way to help save lives.
For Regeneron Pharmaceuticals (NASDAQ: REGN), Gilead Sciences (NASDAQ: GILD), and Moderna (NASDAQ: MRNA), what started as a year of trudging along with existing research was upended by a national emergency.
Image source: Getty Images
Source Fool.com
